Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasminogen-related protein B is a human protein encoded by the PLGLB2 gene. It is predicted to be localized in the extracellular region. It may bind noncovalently to lysine binding sites present in the kringle structures of plasminogen, potentially interfering with fibrin or alpha-2-antiplasmin binding to plasminogen, and might localize activity to sites necessary for extracellular matrix destruction. Its biological function and therapeutic relevance are not well established, and there is no evidence suggesting it is a verified or actionable therapeutic target[2][4][5]. **Explanation:** - The primary and most scientifically accurate canonical name is "Plasminogen-related protein B"[4][5]. - PLGLB2 is the established canonical abbreviation[4][2][5]. - There is no evidence in the literature that PLGLB2/Plasminogen-related protein B is a clinically established *therapeutic target* (i.e., receptor, enzyme, transporter, or molecule with drugs directed at it), nor does it have an established mechanistic role in disease based on current data; therefore, is_target is set to false, and this is_incorrect entry is true when interpreted as a druggable target[2][4][5]. - All major aliases from GeneCards, Wikipedia, and other resources have been included[4][5][2]. - No drug interactions, mechanisms of action, or biomarker roles are established for PLGLB2; no safety concerns are reported in the literature[2][4][5]. - The molecular classification is best described as "Other" due to the lack of evidence for well-defined receptor/enzyme function[5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasminogen-related protein B (PLGLB2).